193 related articles for article (PubMed ID: 36197682)
1. Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial.
Wu F; Chen B; Dong D; Rong W; Wang H; Wang L; Wang S; Jin J; Song Y; Liu Y; Fang H; Tang Y; Li N; Zhu X; Li Y; Wang W; Wu J
JAMA Surg; 2022 Dec; 157(12):1089-1096. PubMed ID: 36197682
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant intensity modulated radiotherapy for a single and small (≤5 cm) hepatitis B virus-related hepatocellular carcinoma predicted to have high risks of microvascular invasion: a randomized clinical trial.
Wei X; Jiang Y; Feng S; Lu C; Huo L; Zhou B; Meng Y; Lau WY; Zheng Y; Cheng S
Int J Surg; 2023 Oct; 109(10):3052-3060. PubMed ID: 37352528
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Chen B; Wu JX; Cheng SH; Wang LM; Rong WQ; Wu F; Wang SL; Jin J; Liu YP; Song YW; Ren H; Fang H; Tang Y; Li N; Li YX; Wang WH
Hepatology; 2021 Nov; 74(5):2595-2604. PubMed ID: 34097307
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma.
Zhang T; Zhao YT; Wang Z; Li CR; Jin J; Jia AY; Wang SL; Song YW; Liu YP; Ren H; Fang H; Bao H; Liu XF; Yu ZH; Li YX; Wang WH
Medicine (Baltimore); 2016 May; 95(21):e3789. PubMed ID: 27227954
[TBL] [Abstract][Full Text] [Related]
5. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Tang LL; Guo R; Zhang N; Deng B; Chen L; Cheng ZB; Huang J; Hu WH; Huang SH; Luo WJ; Liang JH; Zheng YM; Zhang F; Mao YP; Li WF; Zhou GQ; Liu X; Chen YP; Xu C; Lin L; Liu Q; Du XJ; Zhang Y; Sun Y; Ma J
JAMA; 2022 Aug; 328(8):728-736. PubMed ID: 35997729
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels.
Wang WH; Wang Z; Wu JX; Zhang T; Rong WQ; Wang LM; Jin J; Wang SL; Song YW; Liu YP; Ren H; Fang H; Wang WQ; Liu XF; Yu ZH; Li YX
Liver Int; 2015 Dec; 35(12):2603-10. PubMed ID: 25939444
[TBL] [Abstract][Full Text] [Related]
7. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.
Wei X; Jiang Y; Zhang X; Feng S; Zhou B; Ye X; Xing H; Xu Y; Shi J; Guo W; Zhou D; Zhang H; Sun H; Huang C; Lu C; Zheng Y; Meng Y; Huang B; Cong W; Lau WY; Cheng S
J Clin Oncol; 2019 Aug; 37(24):2141-2151. PubMed ID: 31283409
[TBL] [Abstract][Full Text] [Related]
9. Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma.
Wang H; Zhu X; Zhao Y; Dong D; Li L; Cai Y; Li Y; Wang W
BMC Cancer; 2022 Jul; 22(1):771. PubMed ID: 35840914
[TBL] [Abstract][Full Text] [Related]
10. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Li X; Kitpanit S; Lee A; Mah D; Sine K; Sherman EJ; Dunn LA; Michel LS; Fetten J; Zakeri K; Yu Y; Chen L; Kang JJ; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Lee NY
JAMA Netw Open; 2021 Jun; 4(6):e2113205. PubMed ID: 34143193
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non-Small Cell Lung Cancer: The TD-FOREKNOW Randomized Clinical Trial.
Lei J; Zhao J; Gong L; Ni Y; Zhou Y; Tian F; Liu H; Gu Z; Huang L; Lu Q; Wang X; Sun J; Yang E; Wang T; Zhong D; Wang J; Zhao Z; Liu Z; Wang C; Wang X; Lei G; Yan X; Jiang T
JAMA Oncol; 2023 Oct; 9(10):1348-1355. PubMed ID: 37535377
[TBL] [Abstract][Full Text] [Related]
12. [A prospective pilot study of combined intra-operative radiotherapy for centrally located hepatocellular carcinomas].
Liu YH; Wang LM; Wu JX; Rong WQ; Wu F; Li MH; Zhang Y; Lin ST; Zheng YL; Feng QF
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):926-930. PubMed ID: 29262510
[No Abstract] [Full Text] [Related]
13. Image-guided intensity-modulated radiotherapy improves short-term survival for abdominal lymph node metastases from hepatocellular carcinoma.
Zhang H; Chen Y; Hu Y; Yang P; Wang B; Zhang J; Sun J; Zeng Z
Ann Palliat Med; 2019 Nov; 8(5):717-727. PubMed ID: 31865732
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes.
Appel S; Bar J; Ben-Nun A; Perelman M; Alezra D; Urban D; Ben-Ayun M; Honig N; Ofek E; Katzman T; Onn A; Chatterji S; Dubinski S; Tsvang L; Felder S; Kraitman J; Haisraely O; Rabin Alezra T; Lieberman S; Marom EM; Golan N; Simansky D; Symon Z; Lawrence YR
Br J Radiol; 2019 May; 92(1097):20180960. PubMed ID: 30864828
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
16. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
17. An exploratory clinical trial of apatinib combined with intensity-modulated radiation therapy for patients with unresectable hepatocellular carcinoma.
Qiu H; Ke S; Cai G; Wu Y; Wang J; Shi W; Chen J; Peng J; Yu B; Chen Y
Cancer Med; 2023 Jan; 12(1):213-222. PubMed ID: 35633045
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial.
Sun J; Yang L; Shi J; Liu C; Zhang X; Chai Z; Lau WY; Meng Y; Cheng SQ
Radiother Oncol; 2019 Nov; 140():20-25. PubMed ID: 31176205
[TBL] [Abstract][Full Text] [Related]
19. Comparing the efficacy and safety of local-regional treatments for hepatocellular carcinoma with portal/hepatic vein tumor thrombosis in China: a network meta-analysis of randomized controlled trials.
Wu QQ; Gao H; Du SS; Chen YX; Hu Y; Yang P; Hou JZ; Zeng ZC
J BUON; 2021; 26(5):1950-1957. PubMed ID: 34761604
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (<1 cm): a prospective randomized study.
Yu W; Wang W; Rong W; Wang L; Xu Q; Wu F; Liu L; Wu J
J Am Coll Surg; 2014 Mar; 218(3):381-92. PubMed ID: 24559953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
